Nutrigenomic approach to tackle the unpleasant journey to Helicobacter pylori-associated gastric carcinogenesis

Journal of Digestive Diseases

Volumn 12, Issue 3, 2011, Pages 157-164

  Won, Insik ^a   Kim, Yoon Jae ^a   Kim, Seong Jin ^b   Kim, Eun Hee ^a   Hahm, Ki Baik ^a  

^a Gachon University   (South Korea)

^b Graduate School of Complementary and Alternative Medicine   (South Korea)

Author keywords

Cancer prevention; Helicobacter pylori; Korean red ginseng; Nutrigenomics

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA TOCOPHEROL; ANTIBIOTIC AGENT; CELECOXIB; CURCUMIN; POLYPHENOL; PROTON PUMP INHIBITOR; RETINOID; SILYMARIN;

CANCER INCIDENCE; DIETARY INTAKE; GINSENG; HELICOBACTER PYLORI; HUMAN; NUTRIGENOMICS; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROTEIN INDUCTION; REVIEW; STOMACH CARCINOGENESIS;

HELICOBACTER PYLORI; HUMANS; INFLAMMATION; MICROARRAY ANALYSIS; NUTRIGENOMICS; PANAX; PROTEOMICS; STOMACH NEOPLASMS;

EID: 79957609520     PISSN: 17512972     EISSN: 17512980     Source Type: Journal    
DOI: 10.1111/j.1751-2980.2011.00492.x     Document Type: Review

References (34)

1. Marshall BJ, Warren JR. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet 1984; 1: 1311-5.
2. Marshall BJ. Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet 1983; 1: 1273-5.
3. Parsonnet J, Friedman GD, Vandersteen DP etal. Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med 1991; 325: 1127-31.
4. Uemura N, Okamoto S, Yamamoto S etal. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 2001; 345: 784-9.
5. Chung JW, Hahm KB. Rejuvenation of atrophic gastritis in the elderly. J Gastroenterol Hepatol 2010; 25: 434-5.
6. Lee DH, Hahm KB. Inflammatory cytokine gene polymorphisms and gastric cancer. J Gastroenterol Hepatol 2008; 23: 1470-2.
7. MF G. What are the host factors that place an individual at risk for Helicobacter pylori-associated disease? Gastroenterology 1997; 113 (Suppl): S15-20.
8. Suerbaum S, Michetti P. Helicobacter pylori infection. N Engl J Med 2002; 347: 1175-86.
9. Malfertheiner P, Megraud F, O'Morain C etal. Current concepts in the management of Helicobacter pylori infection - the Maastricht 2-2000 Consensus Report. Aliment Pharmacol Ther 2002; 16: 167-80.
10. McLoughlin R, Racz I, Buckley M, O'Connor HJ, O'Morain C. Therapy of Helicobacter pylori. Helicobacter 2004; 9 (Suppl 1): 42-8.
11. Carson CF, Riley TV. Non-antibiotic therapies for infectious diseases. Commun Dis Intell 2003; 27 (Suppl): S143-6.
12. Lee SY, Shin YW, Hahm KB. Phytoceuticals: mighty but ignored weapons against Helicobacter pylori infection. J Dig Dis 2008; 9: 129-39.
13. Kim Y, Park T. DNA microarrays to define and search for genes associated with obesity. Biotechnol J 2010; 5: 99-112.
14. Dong QJ, Wang Q, Xin YN, Li N, Xuan SY. Comparative genomics of Helicobacter pylori. World J Gastroenterol 2009; 15: 3984-91.
15. Wen S, Felley CP, Bouzourene H, Reimers M, Michetti P, Pan-Hammarstrom Q. Inflammatory gene profiles in gastric mucosa during Helicobacter pylori infection in humans. J Immunol 2004; 172: 2595-606.
16. Hofman VJ, Moreilhon C, Brest PD etal. Gene expression profiling in human gastric mucosa infected with Helicobacter pylori. Mod Pathol 2007; 20: 974-89.
17. Lee WM, Kim SD, Kim KS, Song YB. Protopanaxadiol modulates LPS-induced inflammatory activity in murine macrophage RAW264.7 cells. J Ginseng Res 2006; 30: 181-7.
18. Kaput J, Rodriguez RL. Nutritional genomics: the next frontier in the postgenomic era. Physiol Genomics 2004; 16: 166-77.
19. Stover PJ. Nutritional genomics. Physiol Genomics 2004; 16: 161-5.
20. Go VL, Butrum RR, Wong DA. Diet, nutrition, and cancer prevention: the postgenomic era. J Nutr 2003; 133 (Suppl 1): S3830-S6.
21. Choi SR, Lee SA, Kim YJ, Ok CY, Lee HJ, Hahm KB. Role of heat shock proteins in gastric inflammation and ulcer healing. J Physiol Pharmacol 2009; 60 (Suppl 7): 5-17.
22. Kim DK, Lee JA, Kim YB, Lee KM, Hahm KB. A randomized controlled trial assessing Korea red ginseng treatment of Helicobacter pylori-associated chronic gastritis. Korean J Med 2007; 72: 20-8.
23. Lee JS, Kwon KA, Jung HS, Kim JH, Hahm KB. Korea red ginseng on Helicobacter pylori-induced halitosis: newer therapeutic strategy and a plausible mechanism. Digestion 2009; 80: 192-9.
24. Hightower LE. Heat shock, stress proteins, chaperones, and proteotoxicity. Cell 1991; 66: 191-7.
25. Tsukimi Y, Okabe S. Recent advances in gastrointestinal pathophysiology: role of heat shock proteins in mucosal defense and ulcer healing. Biol Pharm Bull 2001; 24: 1-9.
26. Park SW, Oh TY, Kim YS etal. Artemisia asiatica extracts protect against ethanol-induced injury in gastric mucosa of rats. J Gastroenterol Hepatol 2008; 23: 976-84.
27. Oh TY, Yeo M, Han SU etal. Synergism of Helicobacter pylori infection and stress on the augmentation of gastric mucosal damage and its prevention with alpha-tocopherol. Free Radic Biol Med 2005; 38: 1447-57.
28. Tomisato W, Takahashi N, Komoto C, Rokutan K, Tsuchiya T, Mizushima T. Geranylgeranylacetone protects cultured guinea pig gastric mucosal cells from indomethacin. Dig Dis Sci 2000; 45: 1674-9.
29. Kim EH, Park JD, Pyo SN, Rhee DK. Effects of non-saponin red ginseng components on multi-drug resistance. J Ginseng Res 2007; 31: 74-8.
30. Joo HK, Lee SK, Kim HS, Song YJ. Korean red ginseng extract inhibits tumor necrosis factor-alpha-induced monocyte adhesion in the human endothelial cells. J Ginseng Res 2008; 32: 244-9.
31. Park S, Yeo M, Jin JH etal. Inhibitory activities and attenuated expressions of 5-LOX with red ginseng in Helicobacter pylori-infected gastric epithelial cells. Dig Dis Sci 2007; 52: 973-82.
32. Moss SF, Blaser MJ. Mechanisms of disease: inflammation and the origins of cancer. Nat Clin Pract Oncol 2005; 2: 90-7; quiz 1 p following 113.
33. Pollard JW. Tumour-educated macrophages promote tumour progression and metastasis. Nat Rev Cancer 2004; 4: 71-8.
34. Yun TK. Panax ginseng - a non-organ-specific cancer preventive? Lancet Oncol 2001; 2: 49-55.